This week, Wood Mackenzie, a research and consulting firm based in Edinburgh, UK, reviews recent trends in biotechnology stocks. After a sharp drop in late February caused by a market correction that saw indices plunge in all fields, by midMarch the Nasdaq biotechnology index resumed the overall rise that has been its general trend since July 2006.
展开▼
